Back to search

Ireland· IE-PA-PA23458/005/001

REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

A diphtherie-poliomyelitis-tetanus product containing diphtheria toxoid + tetanus toxoid + poliovirus, type 1 + poliovirus, type 2, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 5 of our 19 countries.

ATC J07CA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedREVAXIS Suspension for injection in p…ATCJ07CA01REGISTER NO.IE-PA-PA23458/005/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Diphtherie-poliomyelitis-tetanus is registered in 5 of 19 countries.

Countries holding a registration under ATC J07CA01 (diphtherie-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose

Diphtherie-poliomyelitis-tetanus · ATC J07CA01

5 / 19 countries

  • Belgiumprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Diphtheria toxoid + Tetanus toxoid + POLIOVIRUS, TYPE 1 + Poliovirus, type 2
Manufacturer
Sanofi Winthrop Industrie
Country
Ireland (IE)
ATC code
J07CA01
ATC class
Diphtherie-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23458/005/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5bdbc4c4-36b5-4f3d-a1c8-5b2524fa3d0b
GET /v1/drugs/5bdbc4c4-36b5-4f3d-a1c8-5b2524fa3d0b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07CA01"
  ],
  "strength": null,
  "pa_number": "PA23458/005/001",
  "substances": [
    "Diphtheria toxoid",
    "Tetanus toxoid",
    "POLIOVIRUS, TYPE 1",
    "Poliovirus, type 2",
    "Poliovirus, type 3"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "18/02/2000",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about diphtherie-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.